ADVIKLA · ADVIK LABORATORIES LTD. · Financials
Market Cap
39.75M INR
Shares
19.11M
Volume · Oct 26
2364
Avg daily vol (10 sessions)
3423
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.
Revenue
0
FY2026
Net Income
-10.2M
-13.6%
FY2026
Operating Cash Flow
-5.9M
-3.5%
FY2026
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2026 | FY2025 |
|---|---|---|---|
| INR | 0 | 0 | 0 |
| INR | 1.45M | 1.47M | 1.47M |
| INR | 12K | 8000 | 5000 |
| INR | -10.67M | -10.58M | -8.64M |
| INR | -293K | -379K | 341K |
| INR | -10.38M | -10.2M | -8.98M |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2025–FY2026: 0 in dividends.
Debt Profile
No verified debt profile is available yet. This does not establish that the company has no debt or covenants.